Mesanenin Skuamöz Hücreli Neoplazileri

Benelli A, Varca V, Vaccaro C, et al. Keratinizing squamous metaplasia of the bladder: Our experience and current approaches. Urologia, 2020;87(2):97-100. Doi:10.1177/0391560318810197

Guo CC, Fine SW, Epstein JI. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases. The American journal of surgical pathology, 2006;30(7):883-91. Doi:10.1097/01.pas.0000213283.20166.5a

Harik LR, O'Toole KM. Nonneoplastic lesions of the prostate and bladder. Archives of pathology & laboratory medicine, 2012;136(7):721-34. Doi:10.5858/arpa.2011-0584-RA

Wiener DP, Koss LG, Sablay B, et al. The prevalence and significance of Brunn's nests, cystitis cystica and squamous metaplasia in normal bladders. The Journal of urology, 1979;122(3):317-21. Doi:10.1016/s0022-5347(17)56384-3

Long ED, Shepherd RT. The incidence and significance of vaginal metaplasia of the bladder trigone in adult women. British journal of urology, 1983;55(2):189-94. Doi:10.1111/j.1464-410x.1983.tb06553.x

Jurkiewicz B, Ząbkowski T. Nonkeratinised squamous metaplasia of the urinary bladder in children: a report of case experiences. BioMed research international, 2014;2014:936970. Doi:10.1155/2014/936970

Tasleem AM, Grouse ED, Almushatat A. Keratinising squamous cell metaplasia: when is it safe to stop looking? BMJ case reports, 2018;2018. Doi:10.1136/bcr-2017-223822

Ahmad I, Barnetson RJ, Krishna NS. Keratinizing squamous metaplasia of the bladder: a review. Urologia internationalis, 2008;81(3):247-51. Doi:10.1159/000151398

Khan MS, Thornhill JA, Gaffney E, et al. Keratinising squamous metaplasia of the bladder: natural history and rationalization of management based on review of 54 years experience. European urology, 2002;42(5):469-74. Doi:10.1016/s0302-2838(02)00358-5

Rausch S, Lotan Y, Youssef RF. Squamous cell carcinogenesis and squamous cell carcinoma of the urinary bladder: a contemporary review with focus on nonbilharzial squamous cell carcinoma. Urologic oncology, 2014;32(1):32.e11-6. Doi:10.1016/j.urolonc.2012.11.020

Miliaras D, Vakalopoulos I, Anagnostou E. Squamous cell papilloma of the urinary bladder endoscopically mimicking cancer. Case reports in pathology, 2013;2013:486312. Doi:10.1155/2013/486312

Cheng L, Leibovich BC, Cheville JC, et al. Squamous papilloma of the urinary tract is unrelated to condyloma acuminata. Cancer, 2000;88(7):1679-86. Doi:10.1002/(sici)1097-0142(20000401)88:7<1679::aid-cncr23>3.0.co;2-k

Samarska IV, Epstein JI. Condyloma Acuminatum of Urinary Bladder: Relation to Squamous Cell Carcinoma. The American journal of surgical pathology, 2019;43(11):1547-53. Doi:10.1097/pas.0000000000001339

Chrisofos M, Skolarikos A, Lazaris A, et al. HPV 16/18-associated condyloma acuminatum of the urinary bladder: first international report and review of literature. International journal of STD & AIDS, 2004;15(12):836-8. Doi:10.1258/0956462042563783

McKenney JK. Precursor lesions of the urinary bladder. Histopathology, 2019;74(1):68-76. Doi:10.1111/his.13762

Warrick JI, Kaag M, Raman JD, et al. Squamous Dysplasia of the Urinary Bladder: A Consecutive Cystectomy Series. International journal of surgical pathology, 2016;24(4):306-14. Doi:10.1177/1066896916629783

Shen SS, Al-Ahmadie H, Mahfouz SM. Squamous cell neoplasms. In: Moch H, Humphrey PA, Ulbright TM, Reuter VE, editors. WHO Classification of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC; 2016. p. 108-10.

Erdem GU, Dogan M, Sakin A, et al. Non-Urothelial Bladder Cancer: Comparison of Clinicopathological and Prognostic Characteristics in Pure Adenocarcinoma and Non-Bilharzial Squamous Cell Carcinoma of the Bladder. Oncology research and treatment, 2018;41(4):220-5. Doi:10.1159/000486598

El-Sebaie M, Zaghloul MS, Howard G, et al. Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and management. International journal of clinical oncology, 2005;10(1):20-5. Doi:10.1007/s10147-004-0457-6

Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 2018;68(6):394-424. Doi:10.3322/caac.21492

Guo CC, Gomez E, Tamboli P, et al. Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases. Human pathology, 2009;40(10):1448-52. Doi:10.1016/j.humpath.2009.03.005

Ploeg M, Aben KK, Hulsbergen-van de Kaa CA, et al. Clinical epidemiology of nonurothelial bladder cancer: analysis of the Netherlands Cancer Registry. The Journal of urology, 2010;183(3):915-20. Doi:10.1016/j.juro.2009.11.018

Dahm P, Gschwend JE. Malignant non-urothelial neoplasms of the urinary bladder: a review. European urology, 2003;44(6):672-81. Doi:10.1016/s0302-2838(03)00416-0

Ghoneim MA, el-Mekresh MM, el-Baz MA, et al. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. The Journal of urology, 1997;158(2):393-9.

Abdel-Rahman O. Squamous Cell Carcinoma of the Bladder: A SEER Database Analysis. Clinical genitourinary cancer, 2017;15(3):e463-e8. Doi:10.1016/j.clgc.2016.10.007

El Abiad Y, Bakloul F. Squamous cell carcinoma in a giant bladder diverticulum. The Pan African medical journal, 2015;20:378. Doi:10.11604/pamj.2015.20.378.6765

Abe T, Konari S, Obara W, et al. [A case of squamous cell carcinoma arising in the urinary bladder diverticulum]. Hinyokika kiyo Acta urologica Japonica, 2000;46(8):553-5.

Cho JH, Holley JL. Squamous cell carcinoma of the bladder in a female associated with multiple bladder stones. BMC research notes, 2013;6:354. Doi:10.1186/1756-0500-6-354

Park S, Reuter VE, Hansel DE. Non-urothelial carcinomas of the bladder. Histopathology, 2019;74(1):97-111. Doi:10.1111/his.13719

Manley KV, Hubbard R, Swallow D, et al. Risk factors for development of primary bladder squamous cell carcinoma. Annals of the Royal College of Surgeons of England, 2017;99(2):155-60. Doi:10.1308/rcsann.2016.0343

Kantor AF, Hartge P, Hoover RN, et al. Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder. Cancer research, 1988;48(13):3853-5.

Crawford JM. The origins of bladder cancer. Laboratory investigation; a journal of technical methods and pathology, 2008;88(7):686-93. Doi:10.1038/labinvest.2008.48

Antoni S, Ferlay J, Soerjomataram I, et al. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. European urology, 2017;71(1):96-108. Doi:10.1016/j.eururo.2016.06.010

Lagwinski N, Thomas A, Stephenson AJ, et al. Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases. The American journal of surgical pathology, 2007;31(12):1777-87. Doi:10.1097/PAS.0b013e31805c9cd9

Vakar-López F, Abrams J. Basaloid squamous cell carcinoma occurring in the urinary bladder. Archives of pathology & laboratory medicine, 2000;124(3):455-9. Doi:10.1043/0003-9985(2000)124<0455:bsccoi>2.0.co;2

Gaisa NT, Braunschweig T, Reimer N, et al. Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer. Virchows Archiv : an international journal of pathology, 2011;458(3):301-12. Doi:10.1007/s00428-010-1017-2

Røtterud R, Nesland JM, Berner A, et al. Expression of the epidermal growth factor receptor family in normal and malignant urothelium. BJU international, 2005;95(9):1344-50. Doi:10.1111/j.1464-410X.2005.05497.x

Badr KM, Nolen JD, Derose PB, et al. Muscle invasive schistosomal squamous cell carcinoma of the urinary bladder: frequency and prognostic significance of p53, BCL-2, HER2/neu, and proliferation (MIB-1). Human pathology, 2004;35(2):184-9. Doi:10.1016/j.humpath.2003.10.006

Alexander RE, Hu Y, Kum JB, et al. p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2012;25(11):1526-33. Doi:10.1038/modpathol.2012.103

Liu Z, Meng Y, Cao Y, et al. Expression and prognostic value of PD-L1 in non-schistosoma-associated urinary bladder squamous cell carcinoma. Translational andrology and urology, 2020;9(2):428-36. Doi:10.21037/tau.2020.02.12

Owyong M, Lotan Y, Kapur P, et al. Expression and prognostic utility of PD-L1 in patients with squamous cell carcinoma of the bladder. Urologic oncology, 2019;37(7):478-84. Doi:10.1016/j.urolonc.2019.02.017

Necchi A, Madison R, Raggi D, et al. Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder. European urology, 2020;77(4):548-56. Doi:10.1016/j.eururo.2020.01.003

Hansel DE, Zhang Z, Petillo D, et al. Gene profiling suggests a common evolution of bladder cancer subtypes. BMC medical genomics, 2013;6:42. Doi:10.1186/1755-8794-6-42

Rogers CG, Palapattu GS, Shariat SF, et al. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. The Journal of urology, 2006;175(6):2048-53; discussion 53. Doi:10.1016/s0022-5347(06)00317-x

Shokeir AA. Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment. BJU international, 2004;93(2):216-20. Doi:10.1111/j.1464-410x.2004.04588.x

Kassouf W, Spiess PE, Siefker-Radtke A, et al. Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience. Cancer, 2007;110(4):764-9. Doi:10.1002/cncr.22853

Girgin C, Sezer A, Uc R, et al. Outcome of the treatment of invasive non-transitional cell carcinoma. International journal of urology : official journal of the Japanese Urological Association, 2003;10(10):525-9. Doi:10.1046/j.1442-2042.2003.00679.x

Elsobky E, El-Baz M, Gomha M, et al. Prognostic value of angiogenesis in schistosoma-associated squamous cell carcinoma of the urinary bladder. Urology, 2002;60(1):69-73. Doi:10.1016/s0090-4295(02)01669-2

Johnson DE, Schoenwald MB, Ayala AG, et al. Squamous cell carcinoma of the bladder. The Journal of urology, 1976;115(5):542-4. Doi:10.1016/s0022-5347(17)59272-1

Zaghloul MS, Awwad HK, Akoush HH, et al. Postoperative radiotherapy of carcinoma in bilharzial bladder: improved disease free survival through improving local control. International journal of radiation oncology, biology, physics, 1992;23(3):511-7. Doi:10.1016/0360-3016(92)90005-3

Dotson A, May A, Davaro F, et al. Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy. International journal of clinical oncology, 2019;24(6):706-11. Doi:10.1007/s10147-019-01409-x

Khaled HM, Shafik HE, Zabhloul MS, et al. Gemcitabine and cisplatin as neoadjuvant chemotherapy for invasive transitional and squamous cell carcinoma of the bladder: effect on survival and bladder preservation. Clinical genitourinary cancer, 2014;12(5):e233-40. Doi:10.1016/j.clgc.2014.04.002

el-Sebai I, Sherif M, el-Bolkainy MN, et al. Verrucose squamous carcinoma of bladder. Urology, 1974;4(4):407-10. Doi:10.1016/0090-4295(74)90008-9

Flores MR, Ruiz MR, Florian RE, et al. Pan-urothelial verrucous carcinoma unrelated to schistosomiasis. BMJ case reports, 2009;2009. Doi:10.1136/bcr.08.2008.0787

Lewin F, Cardoso AP, Simardi LH, et al. Verrucous carcinoma of the bladder with koilocytosis unassociated with vesical schistosomiasis. Sao Paulo medical journal = Revista paulista de medicina, 2004;122(2):64-6. Doi:10.1590/s1516-31802004000200006

Hassan M, Qureshi A, Nasir H. Recurrent verrucous carcinoma of the urinary bladder after transurethral resection followed by intravesical mitomycin, and a review of the literature. BMJ case reports, 2016;2016. Doi:10.1136/bcr-2016-216146

Blackmore CC, Ratcliffe NR, Harris RD. Verrucous carcinoma of the bladder. Abdominal imaging, 1995;20(5):480-2. Doi:10.1007/bf01213278